Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa

Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa

Source: 
NY Times, NY
snippet: 

An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.